
1. HOMEPAGE
2. ABOUT ActoGeniX
Mission
Corporate overview
History
Management
Board of Directors
Scientific and Clinical Advisors
3. PRODUCTS
ActoBiotics: A New Class of Biopharmaceuticals to Address Today’s Healthcare Needs
ActoBiotics™, addressing today’s healthcare needs
ActoBiotics™, 3rd generation pharma products
Product pipeline: A Rich Product Pipeline
AG011 for Inflammatory Bowel Disease
AG013 for Oral Mucositis
Preclinical development programs
Oral Mucositis
Celiac Disease
Type 1 Diabetes
Type 2 Diabetes
Allergic diseases
4. TECHNOLOGY PLATFORM
TopAct™: Turning Food Bacteria into ActoBiotics™
TopAct™: Turning Food Bacteria Into ActoBiotics™
TopAct™: How does it work?
Intellectual property
Scientific publications
5. PARTNERS
6. INVESTORS
7. NEWS
8. CAREERS
Current positions
ActoGeniX receives EUR 3 million from the Flanders government through IWT.